Instead of using the controversial body mass index, or BMI, to assess weight, an international group of scientists proposes ...

Novo Nordisk said a higher dose of its drug Wegovy led to greater weight loss in patients during a late-stage trial, but the ...

Body Mass Index (BMI) has limitations as it doesn't distinguish between muscle and fat, leading to misclassification of ...

Despite the staggering impact of obesity on the Black community, columnist Justice B. Hill argues that the issue has been ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

A global group of experts has suggested a new approach to diagnosing and treating obesity that does not rely solely on the much-contested body mass index (BMI).

An international panel of researchers say the measure is too simplistic and focuses too much on weight versus wellness.

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

The way clinicians diagnose obesity is set to change with new guidelines acknowledging that not all obese have the same ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...